SCHEMBL931620

SCHEMBL931620

COc1ccc(C2(c3cccc(Cl)c3)N=C(N)C(S)=N2)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 12/20 0.43
FYN P06241 1/20 0.38
KCNH2 Q12809 2/20 0.38
MAPT P10636 2/20 0.37
TSHR P16473 2/20 0.37
NPC1 O15118 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DHPS P49366 1/20 0.37
CTSD P07339 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
BACE2 Q9Y5Z0 3/20 0.36
MAOA P21397 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
PKM P14618 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932602 0.86 BACE1 (0.56) BACE1FYNKCNH2MAPTTSHR
SCHEMBL932603 0.83 BACE1 (0.41) BACE1FYNKCNH2MAPTTSHR
SCHEMBL932404 0.68 BACE1 (0.86) BACE1KCNH2CTSDBACE2
SCHEMBL932551 0.62 BACE1 (0.40) BACE1KCNH2CTSDBACE2
SCHEMBL943241 0.61 BACE1 (0.46) BACE1KCNH2CTSDBACE2
SCHEMBL29636402 0.61 TRPV4 (0.55) KCNH2MAPTTSHRALDH1A1MEN1
SCHEMBL2127233 0.61 TRPV4 (0.55) KCNH2MAPTTSHRALDH1A1MEN1
SCHEMBL28298273 0.59 TRPV4 (0.53) KCNH2MAPTTSHRALDH1A1MEN1
SCHEMBL12100718 0.58 L3MBTL1 (0.50) KCNH2MAPTSMN1; SMN2DHPSALDH1A1
SCHEMBL1332160 0.57 TRPV4 (0.46) MAPTALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed